|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
OLIPUDASE ALFA |
A16AB25 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004850 |
24-06-2022 |
VALID
|
|
PALOPEGTERIPARATIDE |
H05AA05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005934 |
17-11-2023 |
VALID
|
|
PEGCETACOPLAN |
L04AJ03 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005553 |
13-12-2021 |
VALID
|
|
PEGUNIGALSIDASE ALFA |
A16AB20 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005618 |
04-05-2023 |
VALID
|
|
PEGZILARGINASE |
A16AB24 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005484 |
15-12-2023 |
VALID
|
|
PIFLUFOLASTAT (18F) |
V09IX16 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005520 |
24-07-2023 |
VALID
|
|
PRALSETINIB |
L01EX23 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005413 |
18-11-2021 |
VALID
|
|
QUIZARTINIB |
L01EX11 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005910 |
06-11-2023 |
VALID
|
|
REGDANVIMAB |
J06BD06 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005854 |
12-11-2021 |
VALID
|
|
RELUGOLIX |
L02BX04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005353 |
29-04-2022 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
RETIFANLIMAB |
L01FF10 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006194 |
19-04-2024 |
VALID
|
|
RIMEGEPANT |
N02CD06 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005725 |
25-04-2022 |
VALID
|
|
RITLECITINIB |
L04AF08 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006025 |
15-09-2023 |
VALID
|
|
ROZANOLIXIZUMAB |
L04AG16 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005824 |
05-01-2024 |
VALID
|
|
RUXOLITINIB |
D11AH09 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005843 |
19-04-2023 |
VALID
|
|
SACITUZUMAB GOVITECAN |
L01FX17 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005182 |
22-11-2021 |
VALID
|
|
SINGLE-STRANDED 5' CAPPED MRNA ENCODING RESPIRATORY SYNCYTIAL VIRUS GLYCOPROTEIN F STABILIZED |
J07BX05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006278 |
22-08-2024 |
VALID
|
|
SOMATROGON |
H01AC08 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005633 |
14-02-2022 |
VALID
|
|
SOTATERCEPT |
C02KC06 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005647 |
22-08-2024 |
VALID
|
|
SOTROVIMAB |
J06BD05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005676 |
17-12-2021 |
VALID
|
|
SPARSENTAN |
C09XX01 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005783 |
19-04-2024 |
VALID
|
|
SPESOLIMAB |
L04AC22 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005874 |
09-12-2022 |
VALID
|
|
SUTIMLIMAB |
L04AJ04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005776 |
15-11-2022 |
VALID
|
|
TABELECLEUCEL |
L01XL09 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004577 |
16-12-2022 |
VALID
|
|
TALQUETAMAB |
L01FX29 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005864 |
21-08-2023 |
VALID
|
|
TEBENTAFUSP |
L01XX75 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004929 |
01-04-2022 |
VALID
|
|
TEZEPELUMAB |
R03DX11 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005588 |
19-09-2022 |
VALID
|
|
TISLELIZUMAB |
L01FF09 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005919 |
15-09-2023 |
VALID
|
|
TIXAGEVIMAB AND CILGAVIMAB |
J06BD03 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005788 |
25-03-2022 |
VALID
|
|
TOFERSEN |
N07XX22 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005493 |
29-05-2024 |
VALID
|
|
TORIPALIMAB |
L01FF13 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006120 |
19-09-2024 |
VALID
|
|
TRASTUZUMAB |
L01XC03 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005769 |
15-11-2023 |
VALID
|
|
TREMELIMUMAB |
L01FX20 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004650 |
20-02-2023 |
VALID
|
|
UBLITUXIMAB |
L04AG14 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005914 |
31-05-2023 |
VALID
|
|
VAMOROLONE |
H02AB18 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005679 |
14-12-2023 |
VALID
|
|
VIBEGRON |
G04BD15 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005957 |
27-06-2024 |
VALID
|
|
VOCLOSPORIN |
L04AD03 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005256 |
15-09-2022 |
VALID
|
|
VOXELOTOR |
B06AX03 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004869 |
14-02-2022 |
VALID
|
|
VUTRISIRAN |
N07XX18 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005852 |
15-09-2022 |
VALID
|
|
ZILUCOPLAN |
L04AJ06 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005450 |
01-12-2023 |
VALID
|
|
ZOLBETUXIMAB |
L01FX31 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005868 |
19-09-2024 |
VALID
|
|
CEFEPIME AND BETA-LACTAMASE INHIBITOR |
J01DE51 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005431 |
21-03-2024 |
VALID
|
|
DIFELIKEFALIN |
V03AX04 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005612 |
25-04-2022 |
VALID
|
|
EFGARTIGIMOD ALFA |
L04AA58 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005849 |
10-08-2022 |
VALID
|
|
ELRANATAMAB |
L01FX32 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005908 |
07-12-2023 |
VALID
|
|
LEBRIKIZUMAB |
D11AH10 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005894 |
16-11-2023 |
VALID
|
|
MARIBAVIR |
J05AX10 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
REZAFUNGIN |
J02AX08 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005900 |
22-12-2023 |
VALID
|
|
LOVASTATIN |
C10AA02 |
PT
|
POM
|
03-12-2024 |
|
|
VALID
|